Herrstedt J - Search Results

1

The prevalence, distribution and impact of peripheral neuropathy among Danish patients with cancer - a population-based cross-sectional study.

Nielsen SW, Eckhoff L, Ruhlmann CHB, Herrstedt J, Dalton SO. Nielsen SW, et al. Among authors: herrstedt j. Acta Oncol. 2022 Mar;61(3):363-370. doi: 10.1080/0284186X.2021.2007283. Epub 2021 Nov 30. Acta Oncol. 2022. PMID: 34846991

2

Development of antiemetic therapy in cancer patients.

Herrstedt J. Herrstedt J. Acta Oncol. 1995;34(5):637-40. doi: 10.3109/02841869509094040. Acta Oncol. 1995. PMID: 7546831 Review.

3

Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting.

Ruhlmann C, Herrstedt J. Ruhlmann C, et al. Among authors: herrstedt j. Ther Clin Risk Manag. 2009 Apr;5(2):375-84. doi: 10.2147/tcrm.s4026. Epub 2009 May 20. Ther Clin Risk Manag. 2009. PMID: 19536319 Free PMC article.

4

Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomiting.

Ruhlmann C, Herrstedt J. Ruhlmann C, et al. Among authors: herrstedt j. Expert Rev Anticancer Ther. 2010 Feb;10(2):137-48. doi: 10.1586/era.09.175. Expert Rev Anticancer Ther. 2010. PMID: 20131990 Review.

5

Exercise may reduce depression but not anxiety in self-referred cancer patients undergoing chemotherapy. Post-hoc analysis of data from the 'Body & Cancer' trial.

Midtgaard J, Stage M, Møller T, Andersen C, Quist M, Rørth M, Herrstedt J, Vistisen K, Christiansen B, Adamsen L. Midtgaard J, et al. Among authors: herrstedt j. Acta Oncol. 2011 Jun;50(5):660-9. doi: 10.3109/0284186X.2010.543145. Epub 2011 Jan 12. Acta Oncol. 2011. PMID: 21226544 Clinical Trial.

6

Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting.

Ruhlmann CH, Herrstedt J. Ruhlmann CH, et al. Among authors: herrstedt j. Expert Opin Drug Saf. 2011 May;10(3):449-62. doi: 10.1517/14740338.2011.563235. Epub 2011 Mar 21. Expert Opin Drug Saf. 2011. PMID: 21417835 Review.

7

Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting.

Ruhlmann CH, Herrstedt J. Ruhlmann CH, et al. Among authors: herrstedt j. Expert Rev Anticancer Ther. 2012 Feb;12(2):139-50. doi: 10.1586/era.11.199. Expert Rev Anticancer Ther. 2012. PMID: 22316362 Review.

8

GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients.

Bergmann TK, Vach W, Feddersen S, Eckhoff L, Gréen H, Herrstedt J, Brosen K. Bergmann TK, et al. Among authors: herrstedt j. Acta Oncol. 2013 May;52(4):871-4. doi: 10.3109/0284186X.2012.707787. Epub 2012 Aug 9. Acta Oncol. 2013. PMID: 22877241 No abstract available.

9

Palonosetron and prednisolone for the prevention of nausea and emesis during fractionated radiotherapy and 5 cycles of concomitant weekly cisplatin-a phase II study.

Ruhlmann CH, Belli C, Dahl T, Herrstedt J. Ruhlmann CH, et al. Among authors: herrstedt j. Support Care Cancer. 2013 Dec;21(12):3425-31. doi: 10.1007/s00520-013-1926-0. Epub 2013 Aug 15. Support Care Cancer. 2013. PMID: 23949739 Clinical Trial.

10

Multinational study exploring patients' perceptions of side-effects induced by chemo-radiotherapy.

Ruhlmann CH, Iversen TZ, Okera M, Muhic A, Kristensen G, Feyer P, Hansen O, Herrstedt J. Ruhlmann CH, et al. Among authors: herrstedt j. Radiother Oncol. 2015 Nov;117(2):333-7. doi: 10.1016/j.radonc.2015.09.014. Epub 2015 Sep 11. Radiother Oncol. 2015. PMID: 26372344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page